SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	3.43B
Revenue (ttm)	1.29B
Net Income (ttm)	261.01M
Shares Out	44.59M
EPS (ttm)	5.84
PE Ratio	13.16
Forward PE	n/a
Dividend	5.30 (6.89%)
Ex-Dividend Date	Jul 21, 2025

Volume	8,010
Average Volume	20,751
Open	76.70
Previous Close	77.10
Day's Range	76.70 - 77.00
52-Week Range	72.00 - 110.00
Beta	-0.11
RSI	49.17
Earnings Date	Feb 24, 2026

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, antihypertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anest...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 227
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2024, SYN-TECH Chem. & Pharm.'s revenue was 1.26 billion, an increase of 12.83% compared to the previous year's 1.11 billion. Earnings were 393.28 million, an increase of 56.68%.